Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram for reflux hypersensitivity or functional heartburn with incomplete PPI response
2017-004174-34Phase 4Active
- Sponsor
- Targid
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Functional heartburn (FH) and reflux hypersensitivity (RH) comparing Citalopram with Placebo (2 arms). Primary endpoint: Change in reflux symptom severity. Started Feb 2018; status: active.
02
Drugs
citalopram
03
Conditions
Functional heartburn (FH)reflux hypersensitivity (RH)
Beyond the preview
Go deeper on 2017-004174-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004174-34.